Recognizing The Month Of March 2025 As Endometriosis Awareness Month.
Summary
House Concurrent Resolution 13 designates March 2025 as Endometriosis Awareness Month in Delaware. The resolution describes endometriosis as a common gynecological disease affecting people of reproductive age, often associated with chronic pain, infertility, delayed diagnosis, and misdiagnosis. It also highlights disparities in diagnosis timing for Black and Hispanic women and girls, and notes the broader personal, medical, and economic burdens associated with the disease.
The resolution does not change substantive law or create new regulatory requirements. Instead, it is a commemorative and awareness measure that encourages state agencies, medical organizations, and community groups to promote public education, evidence-based resources, outreach, early detection, treatment, provider education, and culturally competent care. Its practical effect is to elevate attention to endometriosis and support awareness efforts across Delaware during March 2025.
Impact
HCR 13 has no direct legal or fiscal mandate and does not amend the Delaware Code. Its impact is primarily symbolic and educational: it formally recognizes Endometriosis Awareness Month and urges public and private stakeholders to increase awareness, improve provider education, and share resources related to diagnosis and treatment. The resolution may help support advocacy, public health messaging, and future policy or funding discussions related to women’s health and reproductive health care.
Sentiment
The overall sentiment around the resolution appears strongly supportive and noncontroversial. The bill’s findings emphasize the prevalence and seriousness of endometriosis, the long delays in diagnosis, and the need for better awareness and care, which frames the measure as a public health recognition effort. The recorded vote information also suggests broad approval, with the Senate Third Reading showing unanimous support among those voting.
Contention
There is little evidence of substantive contention in the available materials. Because the resolution is commemorative rather than regulatory, there are no apparent disputes over mandates, costs, or enforcement. The only notable policy emphasis is on improving culturally competent care and addressing diagnostic disparities affecting Black and Hispanic women and girls, but the bill presents these issues as reasons for awareness and outreach rather than as points of disagreement.